nach oben

World Journal of Urology

Erschienen in:

01.02.2015 | Topic Paper

Lessons learned from the CROES percutaneous nephrolithotomy global study

verfasst von: Guido M. Kamphuis, Joyce Baard, Matias Westendarp, Jean J. M. C. H. de la Rosette

Erschienen in: World Journal of Urology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to give an overview of the data derived from the CROES PCNL Global Study published previously in 25 articles.

Methods

A comprehensive overview of the outcome of the CROES PCNL Global Study was made, analysed and compared with the current literature and guidelines.

Results

Percutaneous nephrolithotomy (PCNL) was predominately performed in prone position. Although the supine position claims to be favourable over the prone approach, the present study showed a longer operation time and lower stone-free rate (SFR). This might be explained by differences in definition in operation time and methods in the evaluation of residual stones. Ultrasound (US)-guided access proves beneficial in lowering puncture time and radiation exposure. Renal anomalies can safely be treated by PCNL and have similar outcomes to a normal situation. In patients with a solitary kidney, however, there is a lower SFR and more bleeding. Also, severe chronic kidney disease (CKD) patients have less favourable outcome. Morbidity and complications following PCNL are dominated by fever (10.5 %) and bleeding (7.8 %). A matched control analysis confirmed that antibiotic prophylaxis gives a threefold lower post-operative fever rate. In a multivariate analysis, it was elegantly demonstrated that bleeding was directly related to the size of the dilatation: the larger the bore, the higher the chance for bleeding. Elderly patients are at higher risk of complications and longer hospital stay. Overall, obese patients have similar outcome as the general population; however, super-obese (BMI > 40) patients have a higher chance of more severe complications. For the first time, this database illustrated a significant relationship between results and complications of PCNL, and caseload volume. The optimal case volume per centre appears to be 120 PCNL’s/year. Finally, a nomogram has been developed that enables better patient counselling and decision-making.

Conclusion

The CROES PCNL Global Study is the largest real-life study providing new insights into general and special conditions. Because of the vast number of patients included, rare conditions including renal anomalies, solitary kidneys and patient characteristics like severe CKD, super obesity and old age could be analysed. Besides this information, a nomogram was developed. And for the first time, the influence of caseload volume was established.

de la Rosette JJMCH (2009) A platform for global endourological research. J Endourol 23(10):1551–1553PubMedCrossRef

de la Rosette JJMCH, Assimos D, Desai M, Gutierrez J, Lingeman J, Scarpa R, Tefekli A (2011) The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study. J Endourol 25(1):11–17PubMedCrossRef

Gravas S, Montanari E, Geavlete P, Onal B, Skolarikos A, Pearle M, Sun YH, de la Rosette JJMCH (2012) Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol 188(3):843–847PubMedCrossRef

Valdivia JG, Scarpa RM, Duvdevani M, Gross AJ, Nadler RB, Nutahara K, de la Rosette JJMCH (2011) Supine versus prone position during percutaneous nephrolithotomy: a report from the Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study. J Endourol 25(10):1619–1625PubMedCrossRef

Astroza G, Lipkin M, Neisius A, Preminger G, De Sio M, Sodha H, Saussine C, de la Rosette J (2013) Effect of supine vs prone position on outcomes of percutaneous nephrolithotomy in staghorn calculi: results from the clinical research office of the endourology society study. Urology 82(6):1240–1245PubMedCrossRef

Andonian S, Scoffone CM, Louie MK, Gross AJ, Grabe M, Daels FPJ, Shah HN, de la Rosette JJMCH (2013) Does imaging modality used for percutaneous renal access make a difference? A matched case analysis. J Endourol 27(1):24–28PubMedCrossRef

Tefekli A, Esen T, Olbert PJ, Tolley D, Nadler RB, Sun Y-H, Duvdevani M, de la Rosette JJMCH (2013) Isolated upper pole access in percutaneous nephrolithotomy: a large-scale analysis from the CROES percutaneous nephrolithotomy global study. J Urol 189(2):568–573PubMedCrossRef

Lopes T, Sangam K, Alken P, Silva B, Saussine C, Shi L, de la Rosette JJMCH (2011) The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study: tract dilation comparisons in 5537 patients. J Endourol 25(5):755–762PubMedCrossRef

Yamaguchi A, Skolarikos A, Buchholz N-PN, Chomón GB, Grasso M, Saba P, Nakada S, de la Rosette J (2011) Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study. J Endourol 25(6):933–939PubMedCrossRef

10.

Chu DI, Lipkin ME, Wang AJ, Ferrandino MN, Preminger GM, Kijvikai K, Gupta NP, Melekos MD, de la Rosette JJMCH (2013) Lithotrites and postoperative fever: does lithotrite type matter? Results from the Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study. Urol Int 91(3):340–344PubMedCrossRef

11.

Osther PJ, Razvi H, Liatsikos E, Averch T, Crisci A, Garcia JL, Mandal A, de la Rosette JJMCH (2011) Percutaneous nephrolithotomy among patients with renal anomalies: patient characteristics and outcomes; a subgroup analysis of the Clinical Research Office of the Endourological Society global percutaneous nephrolithotomy study. J Endourol 25(10):1627–1632PubMedCrossRef

12.

Bucuras V, Gopalakrishnam G, Wolf JS, Sun Y, Bianchi G, Erdogru T, de la Rosette J (2012) The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study: nephrolithotomy in 189 patients with solitary kidneys. J Endourol 26(4):336–341PubMedCrossRef

13.

Xue W, Pacik D, Boellaard W, Breda A, Botoca M, Rassweiler J, Van Cleynenbreugel B, de la Rosette J (2012) Management of single large nonstaghorn renal stones in the CROES PCNL global study. J Urol 187(4):1293–1297PubMedCrossRef

14.

Anastasiadis A, Onal B, Modi P, Turna B, Duvdevani M, Timoney A, Wolf JS, de la Rosette JJMC (2013) Impact of stone density on outcomes in percutaneous nephrolithotomy (PCNL): an analysis of the Clinical Research Office of the Endourological Society (CROES) PCNL global study database. Scand J Urol 47(6):509–514

15.

Okeke Z, Smith AD, Labate G, D’Addessi A, Venkatesh R, Assimos D, Strijbos WEM, de la Rosette JJMCH (2012) Prospective comparison of outcomes of percutaneous nephrolithotomy in elderly patients versus younger patients. J Endourol 26(8):996–1001PubMedCrossRef

16.

Fuller A, Razvi H, Denstedt JD, Nott L, Pearle M, Cauda F, Bolton D, Celia A, de la Rosette J (2012) The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome. J Urol 188(1):138–144PubMedCrossRef

17.

Sairam K, Scoffone CM, Alken P, Turna B, Sodha HS, Rioja J, Wolf JS, de la Rosette JJMCH (2012) Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL global study. J Urol 188(4):1195–1200PubMedCrossRef

18.

Cormio L, Gonzalez GI, Tolley D, Sofer M, Muslumanoglu A, Klingler H-C, Stolzenburg J-U, de la Rosette JJMCH (2013) Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL global study. World J Urol 31(5):1239–1244PubMedCentralPubMedCrossRef

19.

Cormio L, Preminger G, Saussine C, Buchholz NP, Zhang X, Walfridsson H, Gross AJ, de la Rosette J (2013) Nephrostomy in percutaneous nephrolithotomy (PCNL): does nephrostomy tube size matter? Results from the global PCNL study from the clinical research office endourology society. World J Urol 31(6):1563–1568PubMedCrossRef

20.

Labate G, Modi P, Timoney A, Cormio L, Zhang X, Louie M, Grabe M, de la Rosette JJMCH (2011) The percutaneous nephrolithotomy global study: classification of complications. J Endourol 25(8):1275–1280PubMedCrossRef

21.

Gutierrez J, Smith A, Geavlete P, Shah H, Kural AR, de Sio M, Amón Sesmero JH, Hoznek A, de la Rosette J (2013) Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol 31(5):1135–1140PubMedCentralPubMedCrossRef

22.

de la Rosette JJMCH, Opondo D, Daels FPJ, Giusti G, Kandasami SV, Wolf JS, Grabe M, Gravas S (2012) Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 62:246–255PubMedCrossRef

23.

Opondo D, Tefekli A, Esen T, Labate G, Sangam K, De Lisa A, Shah H, de la Rosette JJMCH (2012) Impact of case volumes on the outcomes of percutaneous nephrolithotomy. Eur Urol 62(6):1181–1187PubMedCrossRef

24.

Smith A, Averch TD, Shahrour K, Opondo D, Daels FPJ, Labate G, Turna B, de la Rosette JJMCH (2013) A nephrolithometric nomogram to predict treatment success of percutaneous nephrolithotomy. J Urol 190(1):149–156PubMedCrossRef

25.

Skolarikos A, Alivizatos G, de la Rosette JJMCH (2005) Percutaneous nephrolithotomy and its legacy. Eur Urol 47(1):22–28PubMedCrossRef

26.

Tuzel E, Aktepe OC, Akdogan B (2013) Prospective comparative study of two protocols of antibiotic prophylaxis in percutaneous nephrolithotomy. J Endourol 27(2):172–176PubMedCrossRef

27.

Seyrek M, Binbay M, Yuruk E, Akman T, Aslan R, Yazici O, Berberoglu Y, Muslumanoglu AY (2012) Perioperative prophylaxis for percutaneous nephrolithotomy: randomized study concerning the drug and dosage. J Endourol 26(11):1431–1436PubMedCrossRef

28.

Demirtas A, Yildirim YE, Sofikerim M, Kaya EG, Akinsal EC, Tombul ST, Ekmekcioglu O, Gulmez I (2012) Comparison of infection and urosepsis rates of ciprofloxacin and ceftriaxone prophylaxis before percutaneous nephrolithotomy: a prospective and randomised study. Sci World J 2012:916381CrossRef

29.

Grabe M, Botto H, Çek M, Naber KG, Pickard RS, Tenke P, Wagenlehner F, Wullt B (2013) Guidelines on urological infections. http://www.uromeb.org

30.

Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS (2009) AUA guideline on the management of staghorn calculi. http://www.auanet.org

31.

Bootsma MJ, Laguna Pes MP, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 54(6):1270–1286PubMedCrossRef

32.

DasGupta R, Grabe M (2009) Preoperative antibiotics before endourologic surgery. J Endourol 23(10):1567–1570PubMedCrossRef

33.

Fourcade RO (1990) Antibiotic prophylaxis with cefotaxime in endoscopic extraction of upper urinary tract stones: a randomized study. J Antimicrob Chemother 26(suppl A):77–83PubMedCrossRef

34.

Baard J, Kamphuis GM, Westendarp M, de la Rosette JJMCH (2014) How well tolerated is supine percutaneous nephrolithotomy? Curr Opin Urol 24(2):184–188

35.

Falahatkar S, Moghaddam AA, Salehi M, Nikpour S, Esmaili F, Khaki N (2008) Complete supine percutaneous nephrolithotripsy comparison with the prone standard technique. J Endourol 22(11):2513–2517PubMedCrossRef

36.

De Sio M, Autorino R, Quarto G, Calabrò F, Damiano R, Giugliano F, Mordente S, D’Armiento M (2008) Modified supine versus prone position in percutaneous nephrolithotomy for renal stones treatable with a single percutaneous access: a prospective randomized trial. Eur Urol 54(1):196–202PubMedCrossRef

37.

Agarwal M, Agrawal MS, Jaiswal A, Kumar D, Yadav H, Lavania P (2011) Safety and efficacy of ultrasonography as an adjunct to fluoroscopy for renal access in percutaneous nephrolithotomy (PCNL). BJU Int 108(8):1346–1349PubMedCrossRef

38.

Basiri A, Ziaee AM, Kianian HR, Mehrabi S, Karami H, Moghaddam SMH (2008) Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: a randomized clinical trial. J Endourol 22(2):281–284PubMedCrossRef

39.

Wezel F, Mamoulakis C, Rioja J, Michel MS, de la Rosette JJMCH, Alken P (2009) Two contemporary series of percutaneous tract dilation for percutaneous nephrolithotomy. J Endourol 23(10):1655–1661PubMedCrossRef

40.

Turna B, Nazli O, Demiryoguran S, Mammadov R, Cal C (2007) Percutaneous nephrolithotomy: variables that influence hemorrhage. Urology 69(4):603–607PubMedCrossRef

41.

Tomaszewski JJ, Smaldone MC, Schuster T, Jackman SV, Averch TD (2010) Factors affecting blood loss during percutaneous nephrolithotomy using balloon dilation in a large contemporary series. J Endourol 24(2):207–211PubMedCrossRef

42.

Davidoff R, Bellman GC (1997) Influence of technique of percutaneous tract creation on incidence of renal hemorrhage. J Urol 157(4):1229–1231PubMedCrossRef

43.

Ganpule AP, Desai MR (2011) Urolithiasis in kidneys with abnormal lie, rotation or form. Curr Opin Urol 21(2):145–153PubMedCrossRef

44.

Basiri A, Shabaninia S, Mir A, Soltani MH (2012) The safety and efficacy of percutaneous nephrolithotomy for management of large renal stones in single- versus double-functioning kidney patients. J Endourol 26(3):235–238PubMedCrossRef

45.

Anagnostou T, Thompson T, Ng C-F, Moussa S, Smith G, Tolley DA (2008) Safety and outcome of percutaneous nephrolithotomy in the elderly: retrospective comparison to a younger patient group. J Endourol 22(9):2139–2145PubMedCrossRef

46.

Abdel-Khalek M, Sheir KZ, Mokhtar AA, Eraky I, Kenawy M, Bazeed M (2004) Prediction of success rate after extracorporeal shock-wave lithotripsy of renal stones—a multivariate analysis model. Scand J Urol Nephrol 38(2):161–167PubMedCrossRef

47.

Akman T, Binbay M, Ugurlu M, Kaba M, Akcay M, Yazici O, Ozgor F, Muslumanoglu AY (2012) Outcomes of retrograde intrarenal surgery compared with percutaneous nephrolithotomy in elderly patients with moderate-size kidney stones: a matched-pair analysis. J Endourol 26(6):625–629PubMedCrossRef

48.

Alyami F, Skinner T, Norman RW (2012) Impact of body mass index on clinical outcomes associated with percutaneous nephrolithotomy. Can Urol Assoc J 7(April):1–5CrossRef

49.

Sari E, Tepeler A, Yuruk E, Resorlu B, Akman T, Binbay M, Armagan A, Unsal A, Muslumanoglu AY (2013) Effect of the body mass index on outcomes of flexible ureterorenoscopy. Urolithiasis 41(6):499–504PubMedCrossRef

50.

Thomas R, Cass S (1993) Extracorporeal shock wave lithotripsy in morbidly obese patients. J Urol 150(1):30–32PubMed

51.

Hippisley-Cox J, Coupland C (2010) Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney scores. BMC Fam Pract 11:49PubMedCentralPubMedCrossRef

52.

Alexander RT, Hemmelgarn BR, Samuel S, Klarenbach SW, Curhan GC (2012) Kidney stones and kidney function loss: a cohort study. Open Access 5287:1–8

53.

Bellman GC, Davidoff R, Candela J, Gerspach J, Kurtz S, Stout L (1997) Tubeless percutaneous renal surgery. J Urol 157(5):1578–1582PubMedCrossRef

54.

Istanbulluoglu MO, Ozturk B, Gonen M, Cicek T, Ozkardes H (2009) Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study. Int Urol Nephrol 41(3):541–545PubMedCrossRef

55.

Sivalingam S, Cannon ST, Nakada SY (2013) Current practices in percutaneous nephrolithotomy among endourologists. J Endourol

56.

Turk C, Knoll T, Petrik A, Sarica K, Skolaricos A, Straub M, Seitz C (2001) Guidelines on urolithiasis. Eur Urol 40(4):362–371CrossRef

57.

Tyson MD, Humphreys MR (2014) Postoperative complications after percutaneous nephrolithotomy: a contemporary analysis by insurance status in the United States. J Endourol 28(3):291–297

58.

Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51(4):899–906PubMedCrossRef

59.

Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22):2117–2127PubMedCrossRef

60.

Konety BR, Dhawan V, Allareddy V, Joslyn S (2005) Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol 173(5):1695–1700PubMedCrossRef

61.

Kadlec AO, Ellimoottil C, Guo R, Trinh Q-D, Sun M, Turk TM (2013) Contemporary volume–outcome relationships for percutaneous nephrolithotomy: results from the nationwide inpatient sample. J Endourol 27(9):1107–1113PubMedCrossRef

62.

Thomas K, Smith NC, Hegarty N, Glass JM (2011) The Guy’s stone score-grading the complexity of percutaneous nephrolithotomy procedures. Urology 78(2):277–281PubMedCrossRef

63.

Opondo D, Gravas S, Joyce A, Pearle M, Matsuda T, Sun YH, Assimos D, Denstedt J, de la Rosette J (2014) Standardization of patient outcomes reporting in percutaneous nephrolithotomy. J Endourol 28(7):767–774

Titel: Lessons learned from the CROES percutaneous nephrolithotomy global study
verfasst von: Guido M. Kamphuis
Joyce Baard
Matias Westendarp
Jean J. M. C. H. de la Rosette
Publikationsdatum: 01.02.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 2/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-014-1367-5

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Shock wave lithotripsy: The new phoenix?

Acute management of stones: When to treat or not to treat?

Diet: from food to stone

Urinary bladder mucosal responses to ischemia